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Abstract
Background: Bilateral stroke following radiofrequency catheter ablation is an unusual complication and may result in 
bilateral altitudinal visual field defects. Bilateral altitudinal visual field defects usually result from prechiasmal pathology 
causing damage to both retinas or optic nerves and rarely from bilateral symmetric damage to the post chiasmal visual 
pathways.
Case presentation: A 48-year-old man complained of visual disturbance on wakening following radiofrequency 
catheter ablation. The patient had a CHADS score of 1 pre-operatively and no complications were noted intra-
operatively. Examination revealed a bilateral superior altitudinal defect and MRI of the brain showed multifocal areas of 
infarction predominantly involving the occipital lobes which correlated to with the visual deficits.
Conclusion: While the risk of thromboembolism and perioperative stroke during radiofrequency catheter ablation is 
small, it is not insignificant.
Background
Radiofrequency catheter ablation is one method of
restoring sinus rhythm in patients with atrial fibrillation
(AF) [1]. It may be associated with serious adverse effects
with a reported peri-operative risk of stroke of between
0% to 7% (median of 0.9%) [1,2]. Described us a first case
of a bilateral altitudinal field defects secondary to bilat-
eral occipital lobe infarction following radiofrequency
cardiac catheter ablation.
Bilateral altitudinal field defects more commonly result
from prechiasmal pathologies affecting both retinas or
optic nerves rather than processes causing bilateral sym-
metric damage to the post-chiasmal visual pathways [3].
Bilateral occipital lobe infarcts, as seen in our case, can
result in bilateral superior altitudinal field defects.
Case presentation
A 48-year-old man underwent percutaneous cathether
ablation for atrial fibrillation. Four years previously he
had been diagnosed with a dilated cardiomyopathy after
presenting with an episode of atrial fibrillation with an
ejection fraction of 17%. He had no history of hyperten-
sion, diabetes or previous strokes. He was commenced on
perindopril, metoprolol and warfarin. Initially, his atrial
fibrillation was paroxysmal, however, over the last nine
months he had noticed an increase in frequency of palpi-
tations. Particularly in the last two months, he felt the
atrial fibrillation was continuous and he was much less
energetic and easily fatigued.
The patient had been anticoagulated with warfarin
until 4 days prior to the procedure when the warfarin was
withheld and anti-coagulation continued with subcutane-
ous low molecular weight heparin. A transoesophageal
echocardiogram had been performed one week prior to
the ablation procedure and showed no pre-formed atrial
thrombus. The patient underwent segmental pulmonary
vein isolation and linear ablation within the left atrium
for substrate modification, as well as linear ablation of the
cavo-tricuspid isthmus for ablation of the classic right
atrial flutter circuit. An irrigated catheter tip was used.
Intravenous heparin was commenced the morning of and
during the procedure with a target activated clotting time
of between 300 and 350 seconds.
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Page 2 of 3On waking from the anaesthetic, the patient immedi-
ately complained of visual disturbance. On examination
the patient had a visual acuity of 2/200 in both eyes and
computerised static perimetry performed day 1 post abla-
tion showed bilateral superior altitudinal field defects
(figure 1). Full neurological examination was undertaken
and in addition to the visual deficit the patient also had
subtle expressive dysphasia with word finding difficulty.
Magnetic resonance imaging (MRI) of the brain on day 2
post ablation showed increased T2 FLAIR signal in both
occipital lobes, extending into the inferomedial aspect of
the left temporal lobe (figure 2), no evidence of older
infarcts were seen. A diagnosis of multifocal cerebral
infarction post catheter ablation was made.
Day 3 post ablation, he developed an episode of atrial
arrhythmia and was commenced on oral amiodarone.
Warfarin was withheld until day 5 post ablation and then
recommenced and maintained at therapeutic levels.
Blood tests for biochemical abnormalities, coagulation
studies and a clotting screen were within normal limits. A
review one week later, showed an improvement in the
visual acuity to 20/60 in the right eye and 20/80 in the left
eye with a persistent bilateral superior altitudinal field
defect.
One year later, visual acuity and visual field remained
unchanged and the patient continued to have ongoing
difficulties with word finding and reading. His atrial
fibrillation, however, was now well controlled on medical
therapy (warfarin, amidarone, perindopril and meto-
prolol).
Discussion
Stroke after catheter ablation for atrial fibrillation is
uncommon. The procedure related risk of stroke varies
from study to study. A survey of 181 centres published in
2005, with a cohort of 9370 undergoing 11762 ablation
procedures observed a procedure related risk of stroke of
0.28% [2]. A recent systematic review of 72 studies
(approximately 16900 patients) observed a median risk of
stroke of 0.9% [1]. While the risk of stroke is low it is a sig-
nificant cause of mortality, being the third most common
reported cause of death in a recently published large case
series [4]. Capatto et al reported that 2 of the 4 deaths
observed in their worldwide survey were due to massive
cerebral thromboemoblism [2].
While the risk of stroke after radiofrequency cardiac
ablation for atrial fibrillation is rare, bilateral stroke or
multiple emboli is even more uncommon. Patient charac-
teristics predisposing to early thromboembolic events
after catheter ablation have been difficult to study due to
the low occurrence of this complication. Oral et al
observed that out of their 7 patients that suffered a
stroke, 6 had 1 or more risk factors for stroke [5]. Con-
versely however, 54% of the patients who did not suffer
from a thromboembolic event also had 1 or more risk fac-
tor for stroke [5]. The majority of studies have focused on
anticoagulation protocols and procedural techniques
when examining thromboembolic risk profiles.
Our patient did not have a high-risk profile for stroke,
with only 1 risk factor identified. He was appropriately
anticoagulated before and during the procedure and the
procedure itself was uncomplicated. The development of
stroke in our patient suggests that there may be an inher-
ent procedure-risk of stroke that may not be completely
eliminated by adequate anti-coagulation.
Higher dose heparin infusions are used intra-opera-
tively to prevent thrombus formation. However, it has
been postulated that while heparin prevents thrombus
formation, it does not prevent coagulum formation [6].
Coagulum is heat-denatured fibrinogen which results
from overheating at electrode surfaces and may embolise
or form a nidus for thrombus formation [6]. Recent stud-
Figure 1 Automated perimetry using Humphrey 30-2 threshold 
program of the right and left eye, showing bilateral superior alti-
tudinal field defects.
Figure 2 (A) MRI scan coronal view, T2 weighted, (B) axial FLAIR 
sequence, (C) Acquired diffusion coefficient and (D) Diffusion 
weighted image, showing area of abnormal signal in both occip-
ital lobes and extending into the inferomedial aspect of the left 
temporal lobe, consistent with acute cerebral infarction.
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out the perioperative period to further reduce the risk of
clot formation and thus the risk of thromboembolic
stroke [7]. This, however, may still carry the risk of a
shower of thromboemboli resulting in multiple cerebro-
vascular infarctions as demonstrated in our case.
Conclusion
While the risk of thromboembolism and perioperative
stroke during radiofrequency catheter ablation is small, it
is not insignificant. To the best of our knowledge, this is
the first case report of a bilateral altitudinal field defects
secondary to bilateral occipital lobe infarction following
radiofrequency cardiac catheter ablation. Further studies
examining risk factors that may put patients at higher risk
of stroke with catheter ablation need to be undertaken so
that therapeutic strategies can be targeted towards these
patients and reduce their risk of debilitating stroke.
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